Haloperidol regulates neurotensin gene expression in striatum of c-fos-deficient mice

Molecular Brain Research

Volumn 47, Issue 1-2, 1997, Pages 275-285

  Shearman, Lauren P ^a,b   Weaver, David R ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

c fos; Gene expression regulation; Haloperidol; Immediate early gene; Knockout mouse; Neurotensin; Striatum

Indexed keywords

HALOPERIDOL; MESSENGER RNA; NEUROTENSIN; PREPROENKEPHALIN; PREPROTACHYKININ;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; GENE EXPRESSION REGULATION; MOUSE; NONHUMAN; ONCOGENE C FOS; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL;

ANIMALS; CORPUS STRIATUM; GENE EXPRESSION; HALOPERIDOL; IN SITU HYBRIDIZATION; MICE; MICE, KNOCKOUT; NEUROTENSIN; PROTO-ONCOGENE PROTEINS C-FOS;

EID: 0030919609     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(97)00058-2     Document Type: Article

References (55)

1. Adams, M.R., Brandon, E.P., Chartoff, E., Idzerda, R.L., Dorsa, D.M. and McKnight, G.S., Disruption of the gene encoding the RIIβ subunit of PKA abolishes transcriptional and behavioral responses to haloperidol in the dorsolateral striatum, Soc. Neurosci. Abstr., 22 (1996) 235.
2. Angulo, J.A. and McEwen, B.S., Molecular aspects of neuropeptide regulation and function in the corpus striatum and nucleus accumbens, Brain Res. Rev., 19 (1994) 1-28.
3. Araki, E., Lipes, M.A., Patti, M-E., Bruning, J.C., Haag, B., Johnson, R.S. and Kahn, C.R., Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene, Nature, 372 (1994) 186-190.
4. 2 receptors, Nature, 377 (1995) 424-428.
5. Baum, M.J., Brown, J.J.G., Kica, E., Rubin, B.S., Johnson, R.S. and Papaioannou, V.E., Effect of a null mutation of the c-fos protooncogene on sexual behavior of male mice, Biol. Reprod., 50 (1994) 1040-1048.
6. Brown, J.R., Ye, H., Bronson, R.T., Dikkes, P. and Greenberg, M.E., A defect in nurturing in mice lacking the immediate early gene fosB, Cell, 86 (1996) 297-309.
7. Bullock, B.P., McNeil, G.P. and Dobner, P.R., Synergistic induction of neurotensin gene expression in PC 12 cells parallels changes in AP-1 activity, Mol. Brain Res., 27 (1994) 232-242.
8. Carter, M.S. and Krause, J.E., Structure, expression, and some regulatory mechanisms of the rat preprotachykinin gene encoding substance P, neurokinin A, neuropeptide K, and neuropeptide y, J. Neurosci., 10 (1990) 2203-2214.
9. Deschenes, R.J., Lorenz, L.J., Haun, R.S., Roos, B.A., Collier, K.J. and Dixon, J.E., Cloning and sequence analysis of a cDNA encoding rat preprocholecystokinin, Proc. Natl. Acad. Sci. USA, 81 (1984) 726-730.
10. Deutch, A.Y. and Zahm, D.S., The current status of neurotensin-dopamine interactions: issues and speculations, Ann NY Acad. Sci., 668 (1992) 232-252.
11. 1A dopamine receptors, Proc. Natl. Acad. Sci. USA, 91 (1994) 12564-12568.
12. 2 dopamine receptor antagonists induce Fos and related proteins in rat striatal neurons, Neuroscience, 37 (1990) 287-294.
13. Fink, J.S., Verhave, M., Kasper, S., Tsukada, T., Mandel, G. and Goodman, R.H., The CGTCA sequence motif is essential for biological activity of the vasoactive intestinal peptide gene cAMP-regulated enhancer, Proc. Natl. Acad. Sci. USA, 85 (1988) 6662-6666.
14. 2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons, Science, 250 (1990) 1429-1432.
15. Graybiel, A.M., Moratalla, R. and Robertson, H.A., Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum, Proc. Natl. Acad. Sci. USA, 87 (1990) 6912-6916.
16. Harrison, R.J., McNeil, G.P. and Dobner, P.R., Synergistic activation of neurotensin/neuromedin N gene expression by c-jun and glucocorticoids: novel effects of Fos family proteins, Mol. Endocrinol., 9 (1995) 981-993.
17. Honrado, G.I., Johnson, R.S., Golombek, D.A., Spiegelman, B.M., Papaioannou, V.E. and Ralph, M.R., The circadian system of c-fos deficient mice, J. Comp. Physiol. A, 178 (1996) 563-570.
18. Hummler, E., Cole, T.J., Blendy, J.A., Ganss, R., Aguzzi, A., Schmid, W., Beermann, F. and Schutz, G., Targeted mutation of the CREB gene: compensation within the CREB/ATF family of transcription factors, Proc. Natl. Acad. Sci. USA, 91 (1994) 5647-5651.
19. Johnson, R.S., Sheng, M., Greenberg, M.E., Kolodner, R.D., Papaioannou, V.E. and Spiegelman, B.M., Targeting of nonexpressed genes in embryonic stem cells via homologous recombination, Science, 245 (1989) 1234-1236.
20. Johnson, R.S., Spiegelman, B.M. and Papaioannou, V., Pleiotropic effects of a null mutation at the c-fos proto-oncogene, Cell, 71 (1992) 577-586.
21. Kinkead, B., Owens, M.J. and Nemeroff, C.B., Ontogeny of the effect of antipsychotic drug treatment on neurotensin concentrations in the rat brain, Synapse, 20 (1995) 244-248.
22. Kislauskis, E., Bullock, B., McNeil, S. and Dobner, P.R., The rat gene encoding neurotensin and neuromedin N: structure, tissue-specific expression, and evolution of exon sequences, J. Biol. Chem., 263 (1988) 4963-4968.
23. Kislauskis, E. and Dobner, P.R., Mutually dependent response elements in the cis-regulatory region of the neurotensin/neuromedin N gene integrate environmental stimuli in PC 12 cells, Neuron, 4 (1990) 783-795.
24. Konradi, C. and Heckers, S., Haloperidol-induced Fos expression in striatum is dependent upon transcription factor cyclic AMP response element binding protein, Neuroscience, 65 (1995) 1051-1061.
25. Konradi, C., Kobierski, L., Nguyen, T.V., Heckers, S. and Hyman, S.E., The cAMP-response-element-binding protein interacts, but Fos protein does not interact, with the proenkephalin enhancer in rat striatum, Proc. Natl. Acad. Sci. USA, 90 (1993) 7005-7009.
26. LeMoine, C., Normand, E., Guitteny, A.F., Fouque, B., Teoule, R. and Bloch, B., Dopamine receptor gene expression by enkephalin neurons in rat forebrain, Proc. Natl. Acad. Sci. USA, 87 (1990) 230-234.
27. LeMoine, C., Normand, E. and Bloch, B., Phenotypical characterization of rat striatal neurons expressing the D1 dopamine receptor gene, Proc. Natl. Acad. Sci. USA, 88 (1991) 4205-4209.
28. MacGibbon, G.A., Lawlor, P.A., Bravo, R. and Dragunow, M., Clozapine and haloperidol produce a different pattern of immediate early gene expression in rat caudate putamen, nucleus accumbens, lateral septum and islands of Calleja, Mol. Brain Res., 23 (1994) 21-32.
29. Merchant, K.M., c-fos antisense oligonucleotide specifically attenuates haloperidol-induced increases in neurotensin/neuromedin N mRNA expression in rat dorsal striatum, Mol. Cell Neurosci., 5 (1994) 336-344.
30. Merchant, K.M. and Miller, M.A., Coexpression of neurotensin and c-fos mRNAs in rat neostriatal neurons following acute haloperidol, Mol. Brain Res., 23 (1994) 271-277.
31. 2 receptors exert tonic regulation of discrete neurotensin systems of the rat brain, Brain Res., 500 (1989) 21-29.
32. Merchant, K.M., Dobie, D.J., Filloux F.M., Totzke, M., Aravagiri, M. and Dorsa D.M., Effects of chronic haloperidol and clozapine treatment on neurotensin and c-fos mRNAs in rat neostriatal subregions, J. Pharmacol. Exp. Ther., 271 (1994) 460-471.
33. Merchant, K.M., Miller, M.A., Ashleigh, E.A. and Dorsa, D.M., Haloperidol rapidly increases the number of neurotensin mRNA-expressing neurons in the neostriatum of rat brain, Brain Res., 540 (1991) 311-314.
34. Merchant, K.M., Dobner, P.R. and Dorsa, D.M., Differential effects of haloperidol and clozapine on neurotensin gene transcription in rat neostriatum, J. Neurosci., 12 (1992) 652-663.
35. Miller, J.C., Induction of c-fos mRNA expression in rat striatum by neuroleptic drugs, J. Neurochem., 54 (1990) 1453-1455.
36. Monstein, H.J., Identification of an AP-1 transcription factor binding site within the human cholecystokinin (CCK) promoter, NeuroReport, 4 (1993) 195-197.
37. Montminy, M.R. and Bilezikjian, L.M., Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene, Nature, 328 (1987) 175-178.
38. Morgan, J.I. and Curran, T., Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes Fos and Jun, Annu. Rev. Neurosci., 14 (1991) 421-451.
39. Naranjo, J.R., Mellstrom, B., Achaval, M. and Sassone-Corsi, P., Molecular pathways of pain: Fos/Jun-mediated activation of a noncanonical AP-1 site in the prodynorphin gene, Neuron, 6 (1991) 607-617.
40. Nicot, A., Berod, A. and Rostene, W., Distribution of prepro-neurotensin/neuromedin N mRNA in the young and adult rat forebrain, Ann. NY Acad. Sci., 668 (1992) 361-365.
41. Nguyen, T.V., Kosofsky, B., Birnbaum, R., Cohen, B.M. and Hyman, S.E., Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine, Proc. Natl. Acad. Sci. USA, 89 (1992) 4270-4274.
42. Paylor, R., Johnson, R.S., Papaioannou, V., Spiegelman, B.M. and Wehner, J.M., Behavioral assessment of c-fos mutant mice, Brain Res., 651 (1994) 275-282.
43. Robertson, G.S., Tetzlaff, W., Bedard, A., St-Jean, M. and Wigle, N., c-fos mediates antipsychotic induced neurotensin gene expression in the rodent striatum, Neuroscience, 67 (1995) 325-344.
44. 2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons, Neuroscience, 49 (1992) 285-296.
45. Sato, M., Kiyama, H., Yoshida, S., Saika, T. and Tohyama, M., Postnatal ontogeny of cells expressing prepro-neurotensin/neuromedin N mRNA in the rat forebrain and midbrain: a hybridization histochemical study involving isotope-labeled and enzyme-labeled probes, J. Comp. Neurol., 310 (1991) 300-315.
46. Sheng, M. and Greenberg, M.E., The regulation and function of c-fos and other immediate early genes in the nervous system, Neuron, 4 (1990) 477-485.
47. Sheng, M., McFadden, G. and Greenberg, M.E., Membrane depolarization and calcium induce c-fos transcription via phosphorylation of transcription factor CREB, Neuron, 4 (1990) 571-582.
48. Simpson, C.S. and Morris, B.J., Haloperidol and fluphenazine induce junB gene expression in rat striatum and nucleus accumbens, J. Neurochem., 63 (1994) 1955-1961.
49. Sonnenberg, J.L., Rauscher, III, F.J., Morgan, J.I. and Curran, T., Regulation of proenkephalin by Fos and Jun, Science, 246 (1989) 1622-1625.
50. Wang, Z-Q., Ovitt, C., Grigoriadis, A.E., Mohle-Steinlein, U., Ruther, U. and Wagner, E.F., Bone and haematopoietic defects in mice lacking c-fos, Nature, 360 (1992) 741-745.
51. Watanabe, Y., Johnson, R.S., Butler, L.S., Binder, D.K., Spiegelman, B.M., Papaioannou, V.E. and McNamara, J.O., Null mutation of c-fos impairs structural and functional plasticities in the kindling model of epilepsy, J. Neurosci., 16 (1996) 3827-3836.
52. Weaver, D.R., Roca, A.L. and Reppert, S.M., c-fos and junB mRNAs are transiently expressed in fetal rodent suprachiasmatic nucleus following dopaminergic stimulation, Dev. Brain Res., 85 (1995) 293-297.
53. 1-adenosine receptor gene expression in fetal rat brain, Dev. Brain Res., 94 (1996) 205-223.
54. 1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses, Cell, 79 (1994) 729-742.
55. 1 receptor mutant mice, Cell, 79 (1994) 945-955.